ESR1 and breast neoplasm: We began by retrieving, preprocessing, and analyzing an existing dataset, which consisted of 58 ER+ stage II or stage III primary breast tumor samples from newly diagnosed female patients who had been treated with Letrozole for a median of 7.2 months prior to surgery.